• Chronic Inflammatory and Neuropathic Pain

    Chronic Inflammatory and Neuropathic Pain

    Keynote Speaker: Clifford J. Woolf (Children's Hospital Boston)Presented by the New York Academy of Sciences, MedImmune, and Grünenthal Gmbh
    Reported by Megan Stephan | Posted August 10, 2011


    In June 2011, chronic pain researchers from academia and industry met at the New York Academy of Sciences for the international conference Chronic Inflammatory and Neuropathic Pain, presented by the Academy, MedImmune, and Grünenthal GmbH, to share their insights on how to improve throughput in the clinical development pipeline for new pain therapies. Ideas were presented at sessions on preclinical research and the identification of new targets, on translational research that might improve success rates in the preclinical to clinical transition, and on effective clinical trial designs that can improve researchers' abilities to detect and measure the activities of new analgesics more efficiently.

    Use the tabs above to find a meeting report and multimedia from this event.


    Presentations available from:

    Miroslav "Misha" Backonja (LifeTree Research and University of Wisconsin–Madison)
    John T. Farrar (University of Pennsylvania)
    Mark J. Field (Grünenthal GmbH, Aachen, Germany)
    Robert W. Gereau (Washington University School of Medicine, St. Louis)
    Ian Gilron (Queen's University, Kingston, Canada)
    Stephen McMahon (King's College London, London, UK)
    Frank Porreca (University of Arizona)
    Bob Rappaport (U.S. Food and Drug Administration, FDA)
    Frank L. Rice (Integrated Tissue Dynamics, LLC and Albany Medical College)
    Laura K. Richman (MedImmune)
    Märta Segerdahl (AstraZeneca, Södertälje, Sweden)
    David Seminowicz (University of Maryland School of Dentistry)
    Linda R. Watkins (University of Colorado at Boulder)
    Katja Wiech (University of Oxford, Oxford, UK)
    Clifford J. Woolf (Children's Hospital Boston)

    Presented by

    • The New York Academy of Sciences
    • MedImmune
    • Grunenthal

    Bronze Sponsor

    Depomed, Inc

    Academy Friends

    Bristol-Myers Squibb Research and Development

    Regeneron Pharmaceuticals, Inc